1. Home
  2. AURA vs CCRN Comparison

AURA vs CCRN Comparison

Compare AURA & CCRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AURA
  • CCRN
  • Stock Information
  • Founded
  • AURA 2007
  • CCRN 1986
  • Country
  • AURA United States
  • CCRN United States
  • Employees
  • AURA N/A
  • CCRN N/A
  • Industry
  • AURA Biotechnology: Pharmaceutical Preparations
  • CCRN Professional Services
  • Sector
  • AURA Health Care
  • CCRN Consumer Discretionary
  • Exchange
  • AURA Nasdaq
  • CCRN Nasdaq
  • Market Cap
  • AURA 396.8M
  • CCRN 447.2M
  • IPO Year
  • AURA 2021
  • CCRN N/A
  • Fundamental
  • Price
  • AURA $5.46
  • CCRN $11.82
  • Analyst Decision
  • AURA Strong Buy
  • CCRN Hold
  • Analyst Count
  • AURA 5
  • CCRN 4
  • Target Price
  • AURA $21.80
  • CCRN $17.91
  • AVG Volume (30 Days)
  • AURA 214.4K
  • CCRN 382.4K
  • Earning Date
  • AURA 11-13-2025
  • CCRN 11-12-2025
  • Dividend Yield
  • AURA N/A
  • CCRN N/A
  • EPS Growth
  • AURA N/A
  • CCRN N/A
  • EPS
  • AURA N/A
  • CCRN N/A
  • Revenue
  • AURA N/A
  • CCRN $1,127,472,000.00
  • Revenue This Year
  • AURA N/A
  • CCRN N/A
  • Revenue Next Year
  • AURA N/A
  • CCRN N/A
  • P/E Ratio
  • AURA N/A
  • CCRN N/A
  • Revenue Growth
  • AURA N/A
  • CCRN N/A
  • 52 Week Low
  • AURA $4.35
  • CCRN $9.67
  • 52 Week High
  • AURA $9.79
  • CCRN $18.33
  • Technical
  • Relative Strength Index (RSI)
  • AURA 40.55
  • CCRN 44.49
  • Support Level
  • AURA $5.18
  • CCRN $10.35
  • Resistance Level
  • AURA $5.71
  • CCRN $12.71
  • Average True Range (ATR)
  • AURA 0.26
  • CCRN 0.59
  • MACD
  • AURA -0.02
  • CCRN -0.08
  • Stochastic Oscillator
  • AURA 27.01
  • CCRN 51.42

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

About CCRN Cross Country Healthcare Inc. $0.0001 Par Value

Cross Country Healthcare Inc is a provider of total talent management services, including strategic workforce solutions, contingent staffing, permanent placement and consultative services for healthcare customers. The company operates in two business segments: the nurse and allied staffing segment, which generates a vast majority of revenue, offers temporary and permanent placements of travel and local nurses and allied professionals, and other outsourcing services.: the Physician Staffing segment provides licensed practitioners across a broad array of specialties, as well as certified registered nurse anesthetists (CRNAs), nurse practitioners (NPs), and physician assistants (PAs) on temporary assignments. The company earns majority of its revenue from the United States.

Share on Social Networks: